Results 71 to 80 of about 156 (117)

Factors associated with time to disability progression in patients with multiple sclerosis. [PDF]

open access: yesRev Peru Med Exp Salud Publica, 2022
Arteaga-Noriega A   +6 more
europepmc   +1 more source

Controversies in neuroimmunology: multiple sclerosis, vaccination, SARS-CoV-2 and other dilemas [PDF]

open access: yesBiomedica, 2022
Reyes-Niño S   +12 more
europepmc   +1 more source

[Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain]. [PDF]

open access: yesAten Primaria
González V   +5 more
europepmc   +1 more source

[15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part II)]. [PDF]

open access: yesRev Neurol, 2023
Fernández O   +23 more
europepmc   +1 more source

Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]

open access: yesBiomedica
Panesso GA   +7 more
europepmc   +1 more source

Decrease in the intensive care unit-acquired weakness with a multicomponent protocol implementation: A quasi-experimental clinical trial [PDF]

open access: yesBiomedica, 2023
Giraldo ND   +13 more
europepmc   +1 more source

[Electrodiagnostic support in an atypical form of amyotrophic lateral sclerosis (Vulpian-Bernhardt syndrome)]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Aguilar-Vázquez CA   +2 more
europepmc   +1 more source

[Consensus document for the management of schistosomiasis in Primary Care]. [PDF]

open access: yesAten Primaria, 2022
Salas-Coronas J   +10 more
europepmc   +1 more source

[Epidemiological and clinical aspects of Guilain-Barré syndrome, 2012-2022]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Hernández-Jardón CH   +1 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy